Ghazvini Siavash 4
4 · ALPHA INNOTECH CORP · Filed Oct 29, 2009
Insider Transaction Report
Form 4
ALPHA INNOTECH CORPAPNO.OB
Ghazvini Siavash
VP - Marketing & Business Dev
Transactions
- Disposition to Issuer
Common Stock
2009-10-28−175,500→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2009-10-28−25,144→ 0 totalExercise: $2.62Exp: 2013-09-15→ Common Stock (25,144 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-10-28$0.15/sh−25,000$3,750→ 0 totalExercise: $1.35Exp: 2016-05-24→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (Riht to Buy)
2009-10-28$0.52/sh−30,000$15,600→ 0 totalExercise: $0.98Exp: 2018-06-16→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-10-28$0.62/sh−30,000$18,600→ 0 totalExercise: $0.88Exp: 2019-09-01→ Common Stock (30,000 underlying)
Footnotes (5)
- [F1]Disposed of pursuant to a merger agreement between the Issuer and Cell Biosciences, Inc. in exchange for a cash payment of $1.50 per share on the effective date of the merger.
- [F2]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled on the effective date of the merger.
- [F3]This option, which provided for monthly vesting in equal installments over four years, was canceled in the merger in exchange for a cash payment of $3,750, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
- [F4]This option, which provided for monthly vesting in equal installments over four years, was canceled in the merger in exchange for a cash payment of $15,600, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
- [F5]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled in the merger in exchange for a cash payment of $18,600, representing the difference between the exercise price of the option and the merger price ($1.50 per share).